Albert C. Ludolph mainly investigates Amyotrophic lateral sclerosis, Pathology, Internal medicine, Neuroscience and Genetics. His Amyotrophic lateral sclerosis research entails a greater understanding of Disease. His Disease research is multidisciplinary, incorporating elements of Neurofilament and Neurology.
Albert C. Ludolph interconnects Magnetic resonance imaging and Anatomy in the investigation of issues within Pathology. Albert C. Ludolph combines subjects such as Gastroenterology, Placebo, Surgery and Endocrinology with his study of Internal medicine. His biological study spans a wide range of topics, including Diffusion MRI and Pathogenesis.
His scientific interests lie mostly in Amyotrophic lateral sclerosis, Pathology, Internal medicine, Neuroscience and Disease. The concepts of his Amyotrophic lateral sclerosis study are interwoven with issues in Genetics, Motor neuron, Neurology and Frontotemporal dementia. His works in Gene and Mutation are all subjects of inquiry into Genetics.
His work deals with themes such as White matter, Magnetic resonance imaging, Diffusion MRI and Fractional anisotropy, which intersect with Pathology. His research in Internal medicine intersects with topics in Endocrinology, Oncology, Cardiology, Gastroenterology and Placebo. His study connects Parkinson's disease and Neuroscience.
His main research concerns Amyotrophic lateral sclerosis, Internal medicine, Disease, Pathology and Spinal muscular atrophy. His research integrates issues of C9orf72, Frontotemporal dementia, Motor neuron, Cell biology and Neurology in his study of Amyotrophic lateral sclerosis. As part of one scientific family, he deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Therapeutic effect, Neurofilament light and Neurofilament.
His Disease study incorporates themes from Quality of life and microRNA, Gene. His Pathology research incorporates elements of Magnetic resonance imaging, Fractional anisotropy, Diffusion MRI and In vivo. In Spinal muscular atrophy, he works on issues like Nusinersen, which are connected to Atrophy and Lumbar puncture.
The scientist’s investigation covers issues in Amyotrophic lateral sclerosis, Internal medicine, Cerebrospinal fluid, Pathology and Nusinersen. His Amyotrophic lateral sclerosis study combines topics from a wide range of disciplines, such as C9orf72, Frontotemporal dementia, Fractional anisotropy, Corticospinal tract and Neurology. His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems.
His Cerebrospinal fluid study is focused on Neuroscience in general. The Disease, Neuroinflammation and Substantia nigra research he does as part of his general Pathology study is frequently linked to other disciplines of science, such as Context, therefore creating a link between diverse domains of science. His study in Nusinersen is interdisciplinary in nature, drawing from both Spinal muscular atrophy, SMA* and Lumbar puncture.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis
Johannes Brettschneider;Kelly Del Tredici;Jon B. Toledo;John L. Robinson.
Annals of Neurology (2013)
Amyotrophic lateral sclerosis—a model of corticofugal axonal spread
Heiko Braak;Johannes Brettschneider;Albert C. Ludolph;Virginia M. Lee.
Nature Reviews Neurology (2013)
Experimental and clinical neurotoxicology
Peter S. Spencer;Herbert H. Schaumburg;Albert C. Ludolph.
(1980)
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.
C. Münch;R. Sedlmeier;T. Meyer;V. Homberg.
Neurology (2004)
Energy metabolism in amyotrophic lateral sclerosis.
Luc Dupuis;Luc Dupuis;Pierre-François Pradat;Albert C Ludolph;Jean-Philippe Loeffler;Jean-Philippe Loeffler.
Lancet Neurology (2011)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin.
Nature Genetics (2016)
Leitlinien für Diagnostik und Therapie in der Neurologie
H. C. Diener;C. Weimar;P. Berlit;G. Deuschl.
(2012)
A yeast functional screen predicts new candidate ALS disease genes
Julien Couthouis;Michael P. Hart;James Shorter;Mariely DeJesus-Hernandez.
Proceedings of the National Academy of Sciences of the United States of America (2011)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi.
Neuron (2018)
A revision of the El Escorial criteria - 2015.
Albert Ludolph;Vivian Drory;Orla Hardiman;Imaharu Nakano.
Amyotrophic Lateral Sclerosis (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Ulm
University of Ulm
Umeå University
Trinity College Dublin
University of Ulm
Utrecht University
University of Lübeck
Swiss Epilepsy Center
University of California, San Diego
University of Ulm
University of Tokyo
Lehigh University
Lehigh University
University of Illinois at Urbana-Champaign
Zhejiang University
Chulalongkorn University
Columbia University
University of Guelph
Max Planck Society
Cornell University
Climate Monitoring and Diagnostics Laboratory
University of Iowa
University of Pennsylvania
University of Helsinki
Duke University
Columbia University